about
Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literatureDynamic simulations on the arachidonic acid metabolic networkSorrell v. IMS Health: issues and opportunities for informaticiansRelative thromboembolic risks associated with COX-2 inhibitors.Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis.Cardiovascular effects of coxibs.Muraglitazar and the FDA: what constitutes drug safety?Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer preventionCOX-2 inhibition and pain management: a review summary.Drug development in inflammatory bowel disease: the role of the FDA.Pain management in neurocritical care.Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression.Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom.
P2860
Q28210177-BF655A46-2CAE-4950-B1BA-6520EF4E7960Q28221357-8C5AC9BA-9271-488D-AD1E-A28A5CC79780Q28709485-65D370D2-D3DB-4333-A8C0-2D729CAB818FQ30437125-20D1469C-BD99-4061-8DE9-EDEF75B9CECCQ34201207-EA6D11BA-6CED-49DB-AC17-C3FC67EA8DC2Q34571335-D229386F-8C03-4950-868A-2B3F71F1EE9DQ36283528-FD6B860C-5BDC-4B24-8D1A-A2F84933BCD6Q36444362-DC098440-3BDB-4AC8-AA62-AE95B3C09B67Q37316907-144C33E3-BB68-45CE-A9B3-74EFF1C1F701Q37754624-86FFFF0E-7196-4B68-8806-0389E02B882FQ37864253-A8332551-03B0-479B-B472-DACB160FDF19Q38124745-80AE3E4C-97DD-46B3-851A-9E2DE8007536Q38958952-CA35A3FE-BA5E-4D3D-9B32-10E73B77C6B9Q42429095-9AB6468A-1395-43D6-A7F6-8CCAA5C74538
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Raising the safety bar--the FDA's coxib meeting.
@ast
Raising the safety bar--the FDA's coxib meeting.
@en
Raising the safety bar--the FDA's coxib meeting.
@nl
type
label
Raising the safety bar--the FDA's coxib meeting.
@ast
Raising the safety bar--the FDA's coxib meeting.
@en
Raising the safety bar--the FDA's coxib meeting.
@nl
prefLabel
Raising the safety bar--the FDA's coxib meeting.
@ast
Raising the safety bar--the FDA's coxib meeting.
@en
Raising the safety bar--the FDA's coxib meeting.
@nl
P356
P1476
Raising the safety bar--the FDA's coxib meeting.
@en
P2093
Susan Okie
P304
P356
10.1056/NEJMP058055
P407
P577
2005-03-01T00:00:00Z